vs
AerSale Corp(ASLE)与BICYCLE THERAPEUTICS PLC(BCYC)财务数据对比。点击上方公司名可切换其他公司
AerSale Corp的季度营收约是BICYCLE THERAPEUTICS PLC的1.9倍($90.9M vs $48.0M),AerSale Corp净利率更高(5.9% vs -42.0%,领先48.0%),BICYCLE THERAPEUTICS PLC同比增速更快(1193.3% vs -4.0%),AerSale Corp自由现金流更多($9.8M vs $-19.9M),过去两年BICYCLE THERAPEUTICS PLC的营收复合增速更高(56.7% vs 0.2%)
AerSale Corp总部位于美国佛罗里达州多拉市,是一家面向航空领域的全球供应商,主要为客运及货运航空公司、政府机构、跨国整机制造商与独立维修机构提供商用喷气飞机二手整机、发动机、航空耗材,并提供航空工程服务,同时该公司也是飞机机队回收协会的成员企业。
Bicycle Therapeutics是一家临床阶段生物制药企业,专注于开发双环肽类创新疗法以解决未被满足的医疗需求,核心管线覆盖肿瘤、罕见病与免疫疾病领域,在欧美布局运营,与全球头部药企达成战略合作推进候选药物落地。
ASLE vs BCYC — 直观对比
营收规模更大
ASLE
是对方的1.9倍
$48.0M
营收增速更快
BCYC
高出1197.3%
-4.0%
净利率更高
ASLE
高出48.0%
-42.0%
自由现金流更多
ASLE
多$29.7M
$-19.9M
两年增速更快
BCYC
近两年复合增速
0.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $90.9M | $48.0M |
| 净利润 | $5.4M | $-20.2M |
| 毛利率 | 34.1% | — |
| 营业利润率 | 7.8% | -51.5% |
| 净利率 | 5.9% | -42.0% |
| 营收同比 | -4.0% | 1193.3% |
| 净利润同比 | 99.7% | 61.1% |
| 每股收益(稀释后) | $0.10 | $-0.29 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASLE
BCYC
| Q4 25 | $90.9M | $48.0M | ||
| Q3 25 | $71.2M | $11.7M | ||
| Q2 25 | $107.4M | $2.9M | ||
| Q1 25 | $65.8M | $10.0M | ||
| Q4 24 | $94.7M | $3.7M | ||
| Q3 24 | $82.7M | $2.7M | ||
| Q2 24 | $77.1M | $9.4M | ||
| Q1 24 | $90.5M | $19.5M |
净利润
ASLE
BCYC
| Q4 25 | $5.4M | $-20.2M | ||
| Q3 25 | $-120.0K | $-59.1M | ||
| Q2 25 | $8.6M | $-79.0M | ||
| Q1 25 | $-5.3M | $-60.8M | ||
| Q4 24 | $2.7M | — | ||
| Q3 24 | $509.0K | $-50.8M | ||
| Q2 24 | $-3.6M | $-39.8M | ||
| Q1 24 | $6.3M | $-26.6M |
毛利率
ASLE
BCYC
| Q4 25 | 34.1% | — | ||
| Q3 25 | 30.2% | — | ||
| Q2 25 | 32.9% | — | ||
| Q1 25 | 27.3% | — | ||
| Q4 24 | 31.4% | — | ||
| Q3 24 | 28.6% | — | ||
| Q2 24 | 28.2% | — | ||
| Q1 24 | 31.8% | — |
营业利润率
ASLE
BCYC
| Q4 25 | 7.8% | -51.5% | ||
| Q3 25 | 4.0% | -558.6% | ||
| Q2 25 | 11.7% | -2965.8% | ||
| Q1 25 | -10.1% | -703.7% | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | 2.4% | -2385.9% | ||
| Q2 24 | -2.4% | -498.3% | ||
| Q1 24 | 5.2% | -162.4% |
净利率
ASLE
BCYC
| Q4 25 | 5.9% | -42.0% | ||
| Q3 25 | -0.2% | -503.7% | ||
| Q2 25 | 8.0% | -2703.8% | ||
| Q1 25 | -8.0% | -608.9% | ||
| Q4 24 | 2.9% | — | ||
| Q3 24 | 0.6% | -1898.4% | ||
| Q2 24 | -4.7% | -425.3% | ||
| Q1 24 | 6.9% | -136.0% |
每股收益(稀释后)
ASLE
BCYC
| Q4 25 | $0.10 | $-0.29 | ||
| Q3 25 | $0.00 | $-0.85 | ||
| Q2 25 | $0.18 | $-1.14 | ||
| Q1 25 | $-0.10 | $-0.88 | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.01 | $-0.74 | ||
| Q2 24 | $-0.07 | $-0.77 | ||
| Q1 24 | $0.12 | $-0.62 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $4.4M | $628.1M |
| 总债务越低越好 | $1.3M | — |
| 股东权益账面价值 | $424.4M | $610.0M |
| 总资产 | $640.5M | $717.6M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势,按日历期对齐
现金及短期投资
ASLE
BCYC
| Q4 25 | $4.4M | $628.1M | ||
| Q3 25 | $5.3M | $648.3M | ||
| Q2 25 | $5.7M | $721.5M | ||
| Q1 25 | $4.7M | $793.0M | ||
| Q4 24 | $4.7M | $879.5M | ||
| Q3 24 | $9.8M | $890.9M | ||
| Q2 24 | $4.3M | $961.4M | ||
| Q1 24 | $2.6M | $457.0M |
总债务
ASLE
BCYC
| Q4 25 | $1.3M | — | ||
| Q3 25 | $1.5M | — | ||
| Q2 25 | $907.0K | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $376.0K | — | ||
| Q2 24 | $522.0K | $30.9M | ||
| Q1 24 | $3.5M | $30.8M |
股东权益
ASLE
BCYC
| Q4 25 | $424.4M | $610.0M | ||
| Q3 25 | $417.1M | $618.5M | ||
| Q2 25 | $415.9M | $668.9M | ||
| Q1 25 | $406.5M | $740.3M | ||
| Q4 24 | $455.6M | $793.1M | ||
| Q3 24 | $451.5M | $831.0M | ||
| Q2 24 | $449.8M | $873.8M | ||
| Q1 24 | $452.0M | $356.0M |
总资产
ASLE
BCYC
| Q4 25 | $640.5M | $717.6M | ||
| Q3 25 | $646.3M | $764.0M | ||
| Q2 25 | $646.7M | $832.2M | ||
| Q1 25 | $646.1M | $883.9M | ||
| Q4 24 | $604.7M | $956.9M | ||
| Q3 24 | $601.5M | $996.7M | ||
| Q2 24 | $598.7M | $1.1B | ||
| Q1 24 | $571.7M | $547.1M |
负债/权益比
ASLE
BCYC
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | 0.04× | ||
| Q1 24 | 0.01× | 0.09× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $11.4M | $-19.3M |
| 自由现金流经营现金流 - 资本支出 | $9.8M | $-19.9M |
| 自由现金流率自由现金流/营收 | 10.8% | -41.5% |
| 资本支出强度资本支出/营收 | 1.7% | 1.2% |
| 现金转化率经营现金流/净利润 | 2.11× | — |
| 过去12个月自由现金流最近4个季度 | $-29.1M | $-252.0M |
8季度趋势,按日历期对齐
经营现金流
ASLE
BCYC
| Q4 25 | $11.4M | $-19.3M | ||
| Q3 25 | $-8.9M | $-71.2M | ||
| Q2 25 | $19.8M | $-72.8M | ||
| Q1 25 | $-45.2M | $-86.4M | ||
| Q4 24 | $37.5M | $-164.7M | ||
| Q3 24 | $10.4M | $-39.8M | ||
| Q2 24 | $-15.3M | $-44.6M | ||
| Q1 24 | $-21.5M | $-70.9M |
自由现金流
ASLE
BCYC
| Q4 25 | $9.8M | $-19.9M | ||
| Q3 25 | $-9.8M | $-71.8M | ||
| Q2 25 | $18.6M | $-73.3M | ||
| Q1 25 | $-47.6M | $-87.0M | ||
| Q4 24 | $32.3M | $-166.0M | ||
| Q3 24 | $8.9M | $-40.3M | ||
| Q2 24 | $-18.9M | $-45.0M | ||
| Q1 24 | $-25.0M | $-70.9M |
自由现金流率
ASLE
BCYC
| Q4 25 | 10.8% | -41.5% | ||
| Q3 25 | -13.8% | -612.3% | ||
| Q2 25 | 17.3% | -2509.7% | ||
| Q1 25 | -72.4% | -871.7% | ||
| Q4 24 | 34.0% | -4475.7% | ||
| Q3 24 | 10.7% | -1504.7% | ||
| Q2 24 | -24.6% | -481.2% | ||
| Q1 24 | -27.7% | -362.9% |
资本支出强度
ASLE
BCYC
| Q4 25 | 1.7% | 1.2% | ||
| Q3 25 | 1.3% | 5.7% | ||
| Q2 25 | 1.1% | 17.1% | ||
| Q1 25 | 3.7% | 6.1% | ||
| Q4 24 | 5.6% | 33.3% | ||
| Q3 24 | 1.9% | 16.3% | ||
| Q2 24 | 4.7% | 4.5% | ||
| Q1 24 | 3.9% | 0.1% |
现金转化率
ASLE
BCYC
| Q4 25 | 2.11× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.31× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 13.89× | — | ||
| Q3 24 | 20.52× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -3.42× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASLE
| Products | $57.8M | 64% |
| Maintenance | $23.2M | 26% |
| Leasing Arrangements | $9.9M | 11% |
BCYC
暂无分部数据